FEATURES OF THERAPY HELICOBACTER PYLORI INFECTION AND CHRONIC IRON DEFICIENCY ANEMIA IN CHILDREN

Abstract

Material and methods: 120 children infected with H. pylori were included in the study, which were subsequently divided into two groups. The main group consisted of 70 children infected with H. pylori and suffering from IDA. The children of the main group were randomly divided into two homogeneous subgroups depending on the therapy: 1a subgroup received eradication therapy (ET): amoxicillin (2 mg/kg 2 times a day), clarithromycin (7.5 mg/kg 2 times a day), esomeprazole 0.5 mg/kg 2 times a day, duration of 10 days with the transition to preparations of ferrous iron in combination with ascorbic acid at the end of the course of ET; 1b-subgroup received therapy only with preparations of ferrous iron in combination with ascorbic acid